Specifically, we demonstrated that the silencing of DDX5 delays PDAC tumour growth (Figure 7A,B), while the OE of DDX5 increases FL118 efficacy to inhibit PDAC cell growth (Figure 7C,D). This evidence concerns the gene DDX5 and neoplasm.